T O'Connor

1.5k total citations
37 papers, 1.2k citations indexed

About

T O'Connor is a scholar working on Parasitology, Infectious Diseases and Virology. According to data from OpenAlex, T O'Connor has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Parasitology, 15 papers in Infectious Diseases and 11 papers in Virology. Recurrent topics in T O'Connor's work include Vector-borne infectious diseases (15 papers), Viral Infections and Vectors (8 papers) and HIV Research and Treatment (7 papers). T O'Connor is often cited by papers focused on Vector-borne infectious diseases (15 papers), Viral Infections and Vectors (8 papers) and HIV Research and Treatment (7 papers). T O'Connor collaborates with scholars based in United States, United Kingdom and Thailand. T O'Connor's co-authors include Janet K. Yamamoto, R. Munn, Niels C. Pedersen, Ellen E. Sparger, Philip R. Andersen, Carol P. Mandell, Linda Lowenstine, Edward B. Breitschwerdt, Ramaswamy Chandrashekar and Steven A. Levy and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

T O'Connor

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T O'Connor United States 15 574 486 467 433 293 37 1.2k
J. Norman Flynn United Kingdom 21 500 0.9× 184 0.4× 631 1.4× 106 0.2× 322 1.1× 40 997
Terri Wasmoen United States 20 133 0.2× 383 0.8× 205 0.4× 169 0.4× 136 0.5× 37 871
Shelly J. Robertson United States 28 280 0.5× 1.2k 2.4× 438 0.9× 163 0.4× 145 0.5× 42 2.2k
Edward Guy United Kingdom 19 115 0.2× 573 1.2× 473 1.0× 1.1k 2.6× 73 0.2× 36 1.3k
J J MacKey United States 17 837 1.5× 447 0.9× 511 1.1× 111 0.3× 84 0.3× 33 1.4k
Béla Dénes Hungary 24 88 0.2× 286 0.6× 190 0.4× 164 0.4× 214 0.7× 83 1.6k
Rose E. Sekulovich United States 14 302 0.5× 224 0.5× 1.4k 2.9× 100 0.2× 251 0.9× 22 1.5k
D Gallo United States 19 224 0.4× 335 0.7× 660 1.4× 106 0.2× 141 0.5× 35 1.3k
Dale Dondero United States 13 492 0.9× 387 0.8× 484 1.0× 88 0.2× 140 0.5× 18 1.1k
Juliana Almeida Leite Brazil 16 372 0.6× 78 0.2× 334 0.7× 117 0.3× 99 0.3× 27 938

Countries citing papers authored by T O'Connor

Since Specialization
Citations

This map shows the geographic impact of T O'Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T O'Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T O'Connor more than expected).

Fields of papers citing papers by T O'Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T O'Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T O'Connor. The network helps show where T O'Connor may publish in the future.

Co-authorship network of co-authors of T O'Connor

This figure shows the co-authorship network connecting the top 25 collaborators of T O'Connor. A scholar is included among the top collaborators of T O'Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T O'Connor. T O'Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loilome, Watcharin, et al.. (2025). Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. PLoS ONE. 20(1). e0317111–e0317111. 2 indexed citations
2.
Deenonpoe, Raksawan, Watcharin Loilome, Poramate Klanrit, et al.. (2025). Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. Scientific Reports. 15(1). 11984–11984.
3.
Ortega‐Rodriguez, Uriel, Chikkathur N. Madhavarao, Tongzhong Ju, et al.. (2025). Effect of different cell culture media on the production and glycosylation of a monoclonal antibody from a CHO cell line. Cytotechnology. 77(3). 81–81. 1 indexed citations
4.
Liang, George H., et al.. (2024). Effects of process intensification on homogeneity of an IgG1:κ monoclonal antibody during perfusion culture. Applied Microbiology and Biotechnology. 108(1). 274–274. 3 indexed citations
6.
Triantafyllou, Evangelos, Cathrin Gudd, Francesca M. Trovato, et al.. (2020). PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury. Journal of Clinical Investigation. 131(4). 80 indexed citations
7.
Sithithaworn, Paiboon, Narong Khuntikeo, Watcharin Loilome, et al.. (2019). Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma. Journal of Clinical and Experimental Hepatology. 9(6). 657–675. 12 indexed citations
8.
Stillman, Brett A., et al.. (2019). Borrelia burgdorferi Antibody Test Results in Dogs Administered 4 Different Vaccines. Topics in companion animal medicine. 37. 100358–100358. 12 indexed citations
9.
O'Connor, T, Anchalee Techasen, Nisana Namwat, et al.. (2017). Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. International Journal of General Medicine. Volume 10. 227–237. 44 indexed citations
10.
Holbrook, Todd C., et al.. (2014). Antibodies Reactive to Ehrlichia spp. Are Common in Oklahoma Horses. Vector-Borne and Zoonotic Diseases. 14(8). 552–556. 13 indexed citations
11.
Yabsley, Michael J., et al.. (2011). Experimental primary and secondary infections of domestic dogs with Ehrlichia ewingii. Veterinary Microbiology. 150(3-4). 315–321. 12 indexed citations
12.
Little, Susan E., T O'Connor, Mason V. Reichard, et al.. (2010). Ehrlichia ewingii infection and exposure rates in dogs from the southcentral United States. Veterinary Parasitology. 172(3-4). 355–360. 36 indexed citations
13.
O'Connor, T, Brett A. Stillman, Regis Krah, et al.. (2010). Evaluation of peptide- and recombinant protein-based assays for detection of anti-Ehrlichia ewingii antibodies in experimentally and naturally infected dogs. American Journal of Veterinary Research. 71(10). 1195–1200. 14 indexed citations
14.
Chandrashekar, Ramaswamy, C.A. Mainville, Melissa J. Beall, et al.. (2010). Performance of a commercially available in-clinic ELISA for the detection of antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis antigen in dogs. American Journal of Veterinary Research. 71(12). 1443–1450. 92 indexed citations
15.
Yabsley, Michael J., Susan E. Little, Ramaswamy Chandrashekar, et al.. (2009). Distribution of Antibodies Reactive to Borrelia lonestari and Borrelia burgdorferi in White-Tailed Deer ( Odocoileus virginianus ) Populations in the Eastern United States. Vector-Borne and Zoonotic Diseases. 9(6). 729–736. 12 indexed citations
16.
Pollack, Seth M., T O'Connor, Jana G. Hashash, & Imad A. Tabbara. (2009). Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Clinical Oncology. 32(6). 618–628. 23 indexed citations
17.
18.
Steinman, R M, T O'Connor, Ronald C. Montelaro, et al.. (1990). Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus. Journal of General Virology. 71(3). 701–706. 48 indexed citations
19.
Yamamoto, Janet K., Ellen E. Sparger, Philip R. Andersen, et al.. (1988). Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. American Journal of Veterinary Research. 49(8). 1246–1258. 397 indexed citations
20.
Mabey, David, Richard S. Tedder, Andrew Hughes, et al.. (1988). Human retroviral infections in The Gambia: prevalence and clinical features. BMJ. 296(6615). 83–86. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026